Therapy of Extensive Chronic Skin Defects after a Traumatic Injury Due to Microbial Contamination Using a Surface Implant Made of a Biocompatible Polycaprolactone-A Pilot Case Study.
Alena Findrik BalogováMartin KožárRadka StaroňováMarek SchnitzerGabriela DancákováJozef ŽivčákRadovan HudákPublished in: Polymers (2022)
This case study describes the use of additive manufacturing technology combining a biodegradable polymer material, polycaprolactone (PCL), and innovative procedures for creating superficial wound dressing, a scaffold in the therapy of extensive contaminated skin defects caused by a traumatic injury. Chronic and contaminated wounds represent a clinical problem and require intensive wound care. The application of a temporary scaffold-facilitated bridging of the wound edges resulted in faster tissue regeneration and a shorter defect closure time, compared to other conservative and surgical methods used in therapy of chronic wounds. Although this procedure has proven to be an optimal alternative to autologous transplants, further studies with a larger number of patients would be beneficial.
Keyphrases
- risk assessment
- heavy metals
- wound healing
- spinal cord injury
- tissue engineering
- end stage renal disease
- soft tissue
- stem cells
- healthcare
- health risk
- ejection fraction
- chronic kidney disease
- newly diagnosed
- drinking water
- drug delivery
- palliative care
- randomized controlled trial
- study protocol
- clinical trial
- quality improvement
- bone marrow
- prognostic factors
- peritoneal dialysis
- climate change
- mesenchymal stem cells
- ionic liquid
- health insurance
- platelet rich plasma
- patient reported
- affordable care act
- double blind